Efficacy of Recombinant Human C1 Esterase Inhibitor (rhC1INH) Across Anatomical Locations in Acute Hereditary Angioedema (HAE) Attacks

Efficacy of Recombinant Human C1 Esterase Inhibitor (rhC1INH) Across Anatomical Locations in Acute Hereditary Angioedema (HAE) Attacks

Time to beginning of symptom relief was defined as first timepoint that severity visual analog scale (VAS) score at an attack location decreased by >=20 mm versus baseline, with persistence to next timepoint.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2017-02, Vol.139 (2), p.AB235-AB235
Hauptverfasser: Baker, James W., MD, FAAAAI, Bernstein, Jonathan A., MD, FAAAAI, Harper, J.R, Relan, A, Riedl, Marc A., MD, MS
Format: Artikel
Sprache:eng
Schlagworte:
Allergy and Immunology
Placebo effect
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Time to beginning of symptom relief was defined as first timepoint that severity visual analog scale (VAS) score at an attack location decreased by >=20 mm versus baseline, with persistence to next timepoint.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2016.12.755